In 1972, soon after then-President Richard Nixon’s newly established Frederick Cancer Research Center (FCRC) hired its first employees, 24-year-old Kunio Nagashima put on a suit and tie and boarded a Boeing 747 at Tokyo’s Haneda International Airport. An electron microscopist from Kyoto University, Nagashima had a one-way ticket in his hand, bound for the United States and ready to take a new job—sight unseen.

The NCI at Frederick Scientific Publications Database added 241 publications by NCI at Frederick researchers between October 1 and December 31, 2021. In comparison, for the period between October 1 and December 31, 2020, the database added 303 publications.

They say two heads are better than one. Two detectives can close a case quicker, and twice the alarms means double the chance of making it to work on time. This is the exact logic that contractor Cooperative Research and Development Agreements (cCRADAs) embody.

HIV plays a direct role in causing blood cell cancers in rare instances, says a new study of HIV and tumor DNA. Scientists have long known that HIV contributes to several cancers by weakening the immune system’s ability to fend off cancer-causing infections. However, this latest study, published in Science Advances this week, is the first to demonstrate HIV as a cause.

A grim statistic is driving Steven Rosenberg’s mission to find new cancer treatments—and his partnership with Frederick National Laboratory to do so. “Every year in the United States, about 600,000 people die of cancer, 90% of whom die of the solid epithelial cancers,” said Rosenberg, the M.D., Ph.D., chief of the National Cancer Institute’s Surgery Branch, head of the Tumor Immunology Section at NCI’s Center for Cancer Research.